mTOR Regulates Mineralocorticoid Receptor Transcriptional Activity by ULK1-Dependent and -Independent Mechanisms

Yusuf Ali,Celso E Gomez-Sanchez,Maria Plonczynski,Aniko Naray-Fejes-Toth,Geza Fejes-Toth,Elise P Gomez-Sanchez
DOI: https://doi.org/10.1210/endocr/bqae015
IF: 5.051
2024-02-07
Endocrinology
Abstract:Abstract The mineralocorticoid receptor (MR) is a transcription factor for genes mediating diverse, cell-specific functions, including trophic effects as well as promoting fluid/electrolyte homeostasis. It was reported that in intercalated cells, phosphorylation of the MR at serine 843 (S843) by Unc-51–like kinase (ULK1) inhibits MR activation and that phosphorylation of ULK1 by mechanistic target of rapamycin (mTOR) inactivates ULK1, and thereby prevents MR inactivation. We extended these findings with studies in M1 mouse cortical collecting duct cells stably expressing the rat MR and a reporter gene. Pharmacological inhibition of ULK1 dose-dependently increased ligand-induced MR transactivation, while ULK1 activation had no effect. Pharmacological inhibition of mTOR and CRISPR/gRNA gene knockdown of rapamycin-sensitive adapter protein of mTOR (Raptor) or rapamycin-insensitive companion of mTOR (Rictor) decreased phosphorylated ULK1 and ligand-induced activation of the MR reporter gene, as well as transcription of endogenous MR-target genes. As predicted, ULK1 inhibition had no effect on aldosterone-mediated transcription in M1 cells with the mutated MR-S843A (alanine cannot be phosphorylated). In contrast, mTOR inhibition dose-dependently decreased transcription in the MR-S843A cells, though not as completely as in cells with the wild-type MR-S843. mTOR, Raptor, and Rictor coprecipitated with the MR and addition of aldosterone increased their phosphorylated, active state. These results suggest that mTOR significantly regulates MR activity in at least 2 ways: by suppressing MR inactivation by ULK1, and by a yet ill-defined mechanism that involves direct association with MR. They also provide new insights into the diverse functions of ULK1 and mTOR, 2 key enzymes that monitor the cell's energy status.
endocrinology & metabolism
What problem does this paper attempt to address?
The paper attempts to address how mTOR (mechanistic target of rapamycin) regulates the transcriptional activity of the mineralocorticoid receptor (MR) through both ULK1-dependent and ULK1-independent mechanisms. ### Main Findings: 1. **Role of ULK1**: - Inhibitors of ULK1 dose-dependently increased MR transcriptional activation induced by mineralocorticoids (such as aldosterone). - Activators of ULK1 had no effect on MR transcriptional activation. 2. **Role of mTOR**: - mTOR inhibitors (such as AZD-8055) significantly reduced the activation of MR reporter genes and the transcription of endogenous MR target genes. - mTOR co-precipitated with its specific adaptor proteins Raptor and Rictor, and the phosphorylation levels of these proteins increased after aldosterone treatment. - mTOR inhibitors reduced the phosphorylation levels of P70S6K and AKT but did not affect the phosphorylation of ERK. 3. **Impact of S843 Mutation**: - In MR-S843A mutant cells, ULK1 inhibitors had no effect on aldosterone-induced transcription. - However, mTOR inhibitors were still able to partially reduce the transcriptional activation of MR-S843A, although the effect was less pronounced than in wild-type MR. ### Conclusion: mTOR regulates MR activity through at least two mechanisms: one by inhibiting ULK1 to prevent MR inactivation, and another through an unknown mechanism involving direct interaction with MR. These results provide new insights into the diverse functions of the key enzymes ULK1 and mTOR in monitoring cellular energy status.